On January 15, 2025, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) posted Advisory Opinion 25-01, a favorable opinion analyzing a pharmaceutical manufacturer’s ...

In honor of Rare Disease Day on February 28, 2025, we will publish a series of posts throughout the month on As Prescribed and Health Law Scan, focusing on issues impacting the rare disease community.

The emergence of Lilly’s bundling strategy for Zepbound and Taltz reflects the unregulated state of patient assistance programs in the commercial market and the need for Congressional intervention.

By HealthDay Staff HealthDay ReporterTUESDAY, March, 3, 2026 (HealthDay News) — A growing number of states are rolling back ...

Florida has one of the highest rates of new HIV diagnoses in the nation. Now, an estimated 16,000 Floridians have lost access ...

Florida's proposed rule change to its AIDS Drug Assistance Program could cut off over 16,000 Floridians from life-saving ...

The state invoked emergency rule-making power for what advocates say will be another emergency, when HIV-positive patients lose medication assistance.

Many of my patients have been treated through this state program over the past 17 years, so I am deeply concerned about threats to its funding. | Opinion ...

Florida has reduced funding and tightened eligibility for its AIDS Drug Assistance Program, limiting access to the widely used HIV medication Biktarvy for thousands of patients, while more than 20 ...

A physician who specializes in HIV treatment writes that proposed cuts to an AIDS drug program proposed by the Florida Dept.